US Stock MarketDetailed Quotes

MBX MBX Biosciences

Watchlist
  • 15.940
  • -0.480-2.92%
Close Nov 19 16:00 ET
  • 15.940
  • 0.0000.00%
Post 16:00 ET
532.67MMarket Cap-9643P/E (TTM)

MBX Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
--277.06M
--55.26M
90.00%80.68M
--80.68M
--42.46M
-Cash and cash equivalents
--132.87M
--12.5M
26.08%30.52M
--30.52M
--24.21M
-Short-term investments
--144.2M
--42.76M
174.80%50.15M
--50.15M
--18.25M
Receivables
--858K
--164K
46.48%208K
--208K
--142K
-Accrued interest receivable
--858K
--164K
46.48%208K
--208K
--142K
Prepaid assets
--2.41M
--3.13M
60.63%2.45M
--2.45M
--1.52M
Other current assets
--838K
--242K
58.33%133K
--133K
--84K
Total current assets
--281.17M
--58.8M
88.79%83.47M
--83.47M
--44.21M
Non current assets
Net PPE
--1.18M
--1.28M
-21.02%665K
--665K
--842K
-Gross PPE
--1.54M
--1.57M
-6.12%843K
--843K
--898K
-Accumulated depreciation
---364K
---289K
-217.86%-178K
---178K
---56K
Non current deferred assets
----
--2.75M
----
----
----
Non current prepaid assets
--50K
--50K
----
----
----
Other non current assets
----
----
19.05%50K
--50K
--42K
Total non current assets
--1.23M
--4.08M
-19.12%715K
--715K
--884K
Total assets
--282.4M
--62.88M
86.67%84.18M
--84.18M
--45.1M
Liabilities
Current liabilities
Payables
--5M
--3.22M
42.52%1.39M
--1.39M
--976K
-accounts payable
--5M
--3.22M
42.52%1.39M
--1.39M
--976K
Current accrued expenses
--3.9M
--3.69M
-14.18%1.02M
--1.02M
--1.19M
Current debt and capital lease obligation
--166K
--162K
11.68%153K
--153K
--137K
-Current capital lease obligation
--166K
--162K
11.68%153K
--153K
--137K
Current liabilities
--10.92M
--8.2M
14.43%3.93M
--3.93M
--3.43M
Non current liabilities
Long term debt and capital lease obligation
--44K
--87K
-47.22%171K
--171K
--324K
-Long term capital lease obligation
--44K
--87K
-47.22%171K
--171K
--324K
Preferred securities outside stock equity
--0
--152.36M
81.64%152.36M
--152.36M
--83.88M
Other non current liabilities
--68K
--125K
193.94%194K
--194K
--66K
Total non current liabilities
--112K
--152.57M
81.23%152.72M
--152.72M
--84.27M
Total liabilities
--11.03M
--160.77M
78.62%156.65M
--156.65M
--87.7M
Shareholders'equity
Share capital
--5K
--2K
0.00%1K
--1K
--1K
-common stock
--5K
--2K
0.00%1K
--1K
--1K
Retained earnings
---121.92M
---103.78M
-75.69%-75.58M
---75.58M
---43.02M
Paid-in capital
--393.18M
--5.91M
643.07%3.05M
--3.05M
--411K
Gains losses not affecting retained earnings
--106K
---15K
1,900.00%60K
--60K
--3K
Total stockholders'equity
--271.37M
---97.89M
-70.09%-72.47M
---72.47M
---42.61M
Total equity
--271.37M
---97.89M
-70.09%-72.47M
---72.47M
---42.61M
Currency Unit
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments --277.06M--55.26M90.00%80.68M--80.68M--42.46M
-Cash and cash equivalents --132.87M--12.5M26.08%30.52M--30.52M--24.21M
-Short-term investments --144.2M--42.76M174.80%50.15M--50.15M--18.25M
Receivables --858K--164K46.48%208K--208K--142K
-Accrued interest receivable --858K--164K46.48%208K--208K--142K
Prepaid assets --2.41M--3.13M60.63%2.45M--2.45M--1.52M
Other current assets --838K--242K58.33%133K--133K--84K
Total current assets --281.17M--58.8M88.79%83.47M--83.47M--44.21M
Non current assets
Net PPE --1.18M--1.28M-21.02%665K--665K--842K
-Gross PPE --1.54M--1.57M-6.12%843K--843K--898K
-Accumulated depreciation ---364K---289K-217.86%-178K---178K---56K
Non current deferred assets ------2.75M------------
Non current prepaid assets --50K--50K------------
Other non current assets --------19.05%50K--50K--42K
Total non current assets --1.23M--4.08M-19.12%715K--715K--884K
Total assets --282.4M--62.88M86.67%84.18M--84.18M--45.1M
Liabilities
Current liabilities
Payables --5M--3.22M42.52%1.39M--1.39M--976K
-accounts payable --5M--3.22M42.52%1.39M--1.39M--976K
Current accrued expenses --3.9M--3.69M-14.18%1.02M--1.02M--1.19M
Current debt and capital lease obligation --166K--162K11.68%153K--153K--137K
-Current capital lease obligation --166K--162K11.68%153K--153K--137K
Current liabilities --10.92M--8.2M14.43%3.93M--3.93M--3.43M
Non current liabilities
Long term debt and capital lease obligation --44K--87K-47.22%171K--171K--324K
-Long term capital lease obligation --44K--87K-47.22%171K--171K--324K
Preferred securities outside stock equity --0--152.36M81.64%152.36M--152.36M--83.88M
Other non current liabilities --68K--125K193.94%194K--194K--66K
Total non current liabilities --112K--152.57M81.23%152.72M--152.72M--84.27M
Total liabilities --11.03M--160.77M78.62%156.65M--156.65M--87.7M
Shareholders'equity
Share capital --5K--2K0.00%1K--1K--1K
-common stock --5K--2K0.00%1K--1K--1K
Retained earnings ---121.92M---103.78M-75.69%-75.58M---75.58M---43.02M
Paid-in capital --393.18M--5.91M643.07%3.05M--3.05M--411K
Gains losses not affecting retained earnings --106K---15K1,900.00%60K--60K--3K
Total stockholders'equity --271.37M---97.89M-70.09%-72.47M---72.47M---42.61M
Total equity --271.37M---97.89M-70.09%-72.47M---72.47M---42.61M
Currency Unit USDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data